Scinopharm Taiwan (TPE:1789) Cash Flow for Dividends : NT$0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Scinopharm Taiwan Cash Flow for Dividends?

Scinopharm Taiwan's cash flow for dividends for the three months ended in Dec. 2024 was NT$0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Scinopharm Taiwan's annual payment of dividends declined from Dec. 2022 (NT$-380 Mil) to Dec. 2023 (NT$-285 Mil) and declined from Dec. 2023 (NT$-285 Mil) to Dec. 2024 (NT$-237 Mil).

Scinopharm Taiwan Cash Flow for Dividends Historical Data

The historical data trend for Scinopharm Taiwan's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinopharm Taiwan Cash Flow for Dividends Chart

Scinopharm Taiwan Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Dividends

Get a 7-Day Free Trial

-213.50

-395.37

-379.56

-284.67

-237.22

Scinopharm Taiwan Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Scinopharm Taiwan Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0 Mil.

Scinopharm Taiwan Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Scinopharm Taiwan's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinopharm Taiwan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Scinopharm Taiwan Ltd (TPE:1789) » Definitions » Cash Flow for Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Nan-Ke 8th Road, Southern Taiwan Science Park, Shan-Hua, Tainan, TWN, 74144

Website

https://www.scinopharm.com

Scinopharm Taiwan Ltd is a specialty and generic drug manufacturing company. The company is primarily engaged in the manufacturing of medicines, chemicals, biological technology services, active pharmaceutical ingredients, albumin medicines, injections, and new small molecule drugs. Schinopharm also conducts consulting and technical services. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The Company's sales revenue mainly arises from the manufacture and sales of Active Pharmaceutical Ingredient and injection products.

Scinopharm Taiwan Headlines

No Headlines